10,10-difluoro-13-dehydroprostacyclin: RN given refers to parent cpd(5Z,9alpha,11alpha,15S)-isomer; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 44144502 |
| MeSH ID | M0082834 |
| Synonym |
|---|
| fluoroprostacyclin |
| 80226-91-1 |
| difluoro-pgi2 |
| prost-5-en-13-yn-1-oic acid, 6,9-epoxy-10,10-difluoro-11,15-dihydroxy-, (5z,9alpha,11alpha,15s)- |
| 10,10-difluoro-13-dehydro-pgx |
| 10,10-difluoro-13-dehydroprostacyclin |
| dfldehprosta |
| cbljbamyhqopfv-wevremhosa-n |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 6 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.37) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 7 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||